2020
DOI: 10.11607/jomi.8114
|View full text |Cite
|
Sign up to set email alerts
|

Diabetic Serum Inhibits Osteoblast Adhesion to Titanium Surface Through Advanced Glycation End Products: An In Vitro Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…However, experiments have shown that this pathway is inhibited in osteoblasts on titanium surfaces and prevents cell attachment and functions through osseointegration ( Ma et al, 2014 ). Diabetes-related osteoporosis is partly due to the formation and accumulation of advanced glycation end products, which can also inhibit the adhesion of osteoblasts to the titanium surface ( Fiorellini et al, 2020 ). Diabetes also reportedly hampers osseointegration by delaying the expression of fibronectin and integrin α5β1 ( Liu et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%
“…However, experiments have shown that this pathway is inhibited in osteoblasts on titanium surfaces and prevents cell attachment and functions through osseointegration ( Ma et al, 2014 ). Diabetes-related osteoporosis is partly due to the formation and accumulation of advanced glycation end products, which can also inhibit the adhesion of osteoblasts to the titanium surface ( Fiorellini et al, 2020 ). Diabetes also reportedly hampers osseointegration by delaying the expression of fibronectin and integrin α5β1 ( Liu et al, 2015 ).…”
Section: Introductionmentioning
confidence: 99%